Jiyun Lv

722 total citations
9 papers, 546 citations indexed

About

Jiyun Lv is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Jiyun Lv has authored 9 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 4 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in Jiyun Lv's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Jiyun Lv is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Jiyun Lv collaborates with scholars based in China and United States. Jiyun Lv's co-authors include George Lau, Junliang Fu, Zheng Zhang, Lei Jin, Liming Chen, Shuang-jie Yu, Yuanyuan Li, Fu‐Sheng Wang, Hua Geng and Sa Lv and has published in prestigious journals such as Hepatology, BioMed Research International and Antiviral Research.

In The Last Decade

Jiyun Lv

8 papers receiving 534 citations

Peers

Jiyun Lv

HEPAT

SURGE

GENET

EPIDE

ONCOL

Eunice Amofah United Kingdom

Xiao-Shun He China

Kunpeng Hu China

Ji Hyang Kim South Korea

Sabrina Ingrao Italy

Dirk Nierhoff Germany

Meihai Deng China

Tongyu Lu China

Hirokatsu Katagiri Japan

M Hisanaga Japan

Eunice Amofah United Kingdom

Jiyun Lv

336 ×1.3

HEPAT

259 ×1.4

SURGE

135 ×0.8

GENET

148 ×1.0

EPIDE

74 ×0.7

ONCOL

Citations per year, relative to Jiyun Lv Jiyun Lv (= 1×) peers Eunice Amofah

Countries citing papers authored by Jiyun Lv

Since Specialization

Citations

This map shows the geographic impact of Jiyun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyun Lv more than expected).

Fields of papers citing papers by Jiyun Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyun Lv. The network helps show where Jiyun Lv may publish in the future.

Co-authorship network of co-authors of Jiyun Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyun Lv. A scholar is included among the top collaborators of Jiyun Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyun Lv. Jiyun Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Su, Lishan, Yang‐Xin Fu, Shuye Zhang, et al.. (2020). B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation. UNC Libraries.

2.

Liu, Yuan, Jiyun Lv, Jianfei Shi, et al.. (2014). Targeting the Raft-Associated Akt Signaling in Hepatocellular Carcinoma. BioMed Research International. 2014. 1–9. 14 indexed citations

3.

Zhang, Zheng, Hu Lin, Ming Shi, et al.. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology. 27(s2). 112–120. 273 indexed citations

4.

Yang, Yongping, Yinying Lu, Chunping Wang, et al.. (2012). Cryotherapy is Associated with Improved Clinical Outcomes of Sorafenib Therapy for Advanced Hepatocellular Carcinoma. Cell Biochemistry and Biophysics. 63(2). 159–169. 23 indexed citations

5.

Fu, Junliang, Zheng Zhang, Lin Zhou, et al.. (2012). Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Hepatology. 58(1). 139–149. 159 indexed citations

6.

Wang, Chunping, Yinying Lu, Hong Wang, et al.. (2012). Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 4(2). 188–196. 5 indexed citations

7.

Zhong, Yanwei, Jiyun Lv, Jin Li, et al.. (2011). Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. Antiviral Research. 93(1). 185–190. 13 indexed citations

8.

Yang, Yongping, Yinying Lu, Chunping Wang, et al.. (2011). Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 3(2). 171–180. 8 indexed citations

9.

Yang, Yongping, Chunping Wang, Yinying Lu, et al.. (2011). Outcomes of ultrasound‐guided percutaneous argon‐helium cryoablation of hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences. 19(6). 674–684. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact